Related Experiment Videos
Central nervous system metastases in malignant melanoma
Neurosurgery
|January 1, 1981
Summary
Male patients with invasive malignant melanoma, particularly those with head/neck or oral primary lesions, face a higher risk of central nervous system (CNS) metastases. Age and race were not significant risk factors in this study.
Area of Science:
- Oncology
- Neurology
- Pathology
Background:
- Malignant melanoma is a significant cancer with potential for widespread metastasis.
- Central nervous system (CNS) metastases from melanoma present a therapeutic challenge and impact patient prognosis.
Purpose of the Study:
- To identify patient and disease characteristics associated with the development of CNS metastases in malignant melanoma.
- To describe the clinical presentation and extent of CNS involvement in melanoma patients.
Main Methods:
- Retrospective analysis of 1341 patients with histologically confirmed malignant melanoma.
- Evaluation of demographic, clinical, and pathological factors correlating with CNS metastasis development.
Main Results:
- 107 patients (approximately 8%) developed CNS metastases.
- Higher incidence of CNS metastases observed in male patients, those with invasive primary lesions (Clark's system), and head/neck or oral mucosal melanomas.
- Age and race were not significant predictors.
- Single CNS metastases occurred in 48.8%, multiple cerebral lesions in 37.2%.
- CNS metastasis was the sole metastatic site in 22%, with other organs involved in 41% (second organ) and 20% (third organ).
Conclusions:
- Specific patient and tumor characteristics predict CNS metastasis risk in malignant melanoma.
- Understanding these risk factors can aid in early detection and management strategies for CNS involvement.